GlassScriptPhysician profile
Ashley Dawn Pack
NPI 1508104050
$461.30
in general payments reported to CMS, 2019-2025
11 companies · $47.39 in 2025
The $47.39 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.32 · 2022: $75.24 · 2023: $53.69 · 2024: $191 · 2025: $47.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $123.75 | 2022-2024 | Nexplanon |
| Myovant Sciences INC. | $76.38 | 2021 | |
| Hologic Sales and Service, LLC | $72.40 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Amgen INC. | $44.54 | 2024 | Tavneos |
| Astellas Pharma US INC | $37.37 | 2024 | Veozah |
| Exeltis, USA INC. | $28.16 | 2022 | |
| Pfizer INC. | $17.94 | 2021 | |
| Coopersurgical, INC. | $17.16 | 2024 | Paragard T 380a |
| Avion Pharmaceuticals | $15.63 | 2022 | |
| Merck Sharp & Dohme LLC | $14.60 | 2024 | Gardasil, Gardasil 9 |
| Baxter Healthcare | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Pack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.